These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 8975319)
1. [Antioncogene p53 and apoptosis response: new hypotheses on the molecular bases of tumor resistance to radiotherapy]. Corvò R Radiol Med; 1996 Sep; 92(3):298-302. PubMed ID: 8975319 [TBL] [Abstract][Full Text] [Related]
2. [Tumor suppressor gene p53: mechanisms of action in cell proliferation and death]. Mendoza-Rodríguez CA; Cerbón MA Rev Invest Clin; 2001; 53(3):266-73. PubMed ID: 11496714 [TBL] [Abstract][Full Text] [Related]
3. Enhanced sensitivity to anti-benzo(a)pyrene-diol-epoxide DNA damage correlates with decreased global genomic repair attributable to abrogated p53 function in human cells. Wani MA; Zhu Q; El-Mahdy M; Venkatachalam S; Wani AA Cancer Res; 2000 Apr; 60(8):2273-80. PubMed ID: 10786695 [TBL] [Abstract][Full Text] [Related]
4. p53 apoptotic response to DNA damage dependent on bcl2 but not bax in head and neck squamous cell carcinoma lines. Crowe DL; Sinha UK Head Neck; 2006 Jan; 28(1):15-23. PubMed ID: 16302195 [TBL] [Abstract][Full Text] [Related]
5. [Cell cycle regulation after exposure to ionizing radiation]. Teyssier F; Bay JO; Dionet C; Verrelle P Bull Cancer; 1999 Apr; 86(4):345-57. PubMed ID: 10341340 [TBL] [Abstract][Full Text] [Related]
6. A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function. Kokontis JM; Wagner AJ; O'Leary M; Liao S; Hay N Oncogene; 2001 Feb; 20(6):659-68. PubMed ID: 11313999 [TBL] [Abstract][Full Text] [Related]
7. The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer. Smith ND; Rubenstein JN; Eggener SE; Kozlowski JM J Urol; 2003 Apr; 169(4):1219-28. PubMed ID: 12629332 [TBL] [Abstract][Full Text] [Related]
8. P53 regulation and function in normal cells and tumors. Liu Y; Kulesz-Martin M Medicina (B Aires); 2000; 60 Suppl 2():9-11. PubMed ID: 11188940 [TBL] [Abstract][Full Text] [Related]
9. Induction of apoptosis and cell cycle-specific change in expression of p53 in normal lymphocytes and MOLT-4 leukemic cells by nitrogen mustard. Bhatia U; Danishefsky K; Traganos F; Darzynkiewicz Z Clin Cancer Res; 1995 Aug; 1(8):873-80. PubMed ID: 9816057 [TBL] [Abstract][Full Text] [Related]
10. [Molecular bases of the programmed cell death process: implications of tumor suppressor protein p53 and other proteins in the control of cell cycle. Mechanisms of apoptotic action. Review]. Merino JJ; Cordero-Campaña MI Invest Clin; 1998 Dec; 39(4):323-58. PubMed ID: 9927805 [TBL] [Abstract][Full Text] [Related]
11. Dissociation between cell cycle arrest and apoptosis can occur in Li-Fraumeni cells heterozygous for p53 gene mutations. Delia D; Goi K; Mizutani S; Yamada T; Aiello A; Fontanella E; Lamorte G; Iwata S; Ishioka C; Krajewski S; Reed JC; Pierotti MA Oncogene; 1997 May; 14(18):2137-47. PubMed ID: 9174049 [TBL] [Abstract][Full Text] [Related]
12. Role of p53 in the regulation of irradiation-induced apoptosis in neuroblastoma cells. Jasty R; Lu J; Irwin T; Suchard S; Clarke MF; Castle VP Mol Genet Metab; 1998 Oct; 65(2):155-64. PubMed ID: 9787107 [TBL] [Abstract][Full Text] [Related]
13. The dual role of mutant p53 protein in chemosensitivity of human cancers. Mueller H; Eppenberger U Anticancer Res; 1996; 16(6B):3845-8. PubMed ID: 9042268 [TBL] [Abstract][Full Text] [Related]
14. Endogenous p53 regulation and function in early stage Friend virus-induced tumor progression differs from that following DNA damage. Kelley LL; Hicks GG; Hsieh FF; Prasher JM; Green WF; Miller MD; Eide EJ; Ruley HE Oncogene; 1998 Sep; 17(9):1119-30. PubMed ID: 9764822 [TBL] [Abstract][Full Text] [Related]
15. Differential chemosensitivity of breast cancer cells to ganciclovir treatment following adenovirus-mediated herpes simplex virus thymidine kinase gene transfer. Li PX; Ngo D; Brade AM; Klamut HJ Cancer Gene Ther; 1999; 6(2):179-90. PubMed ID: 10195885 [TBL] [Abstract][Full Text] [Related]
16. A serine 37 mutation associated with two missense mutations at highly conserved regions of p53 affect pro-apoptotic genes expression in a T-lymphoblastoid drug resistant cell line. Cinti C; Claudio PP; Luca AD; Cuccurese M; Howard CM; D'Esposito M; Paggi MG; Sala DL; Azzoni L; Halazonetis TD; Giordano A; Maraldi NM Oncogene; 2000 Oct; 19(44):5098-105. PubMed ID: 11042698 [TBL] [Abstract][Full Text] [Related]
17. Oncogenic mutation of the p53 gene derived from head and neck cancer prevents cells from undergoing apoptosis after DNA damage. Kawamata H; Omotehara F; Nakashiro K; Uchida D; Shinagawa Y; Tachibana M; Imai Y; Fujimori T Int J Oncol; 2007 May; 30(5):1089-97. PubMed ID: 17390010 [TBL] [Abstract][Full Text] [Related]
18. The role of p53-mediated apoptosis as a crucial anti-tumor response to genomic instability: lessons from mouse models. Attardi LD Mutat Res; 2005 Jan; 569(1-2):145-57. PubMed ID: 15603759 [TBL] [Abstract][Full Text] [Related]
19. Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis. Andrews GA; Xi S; Pomerantz RG; Lin CJ; Gooding WE; Wentzel AL; Wu L; Sidransky D; Grandis JR Head Neck; 2004 Oct; 26(10):870-7. PubMed ID: 15390206 [TBL] [Abstract][Full Text] [Related]
20. [The p53 gene and protein in 2005: new results, promising opportunities]. Szoke D; Sipos F; Spisák S; Molnár B; Tulassay Z Orv Hetil; 2005 Jul; 146(30):1587-94. PubMed ID: 16136736 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]